Docusate Sodium And Sennosides Tablet
NDC Package 62993-0002-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Docusate Sodium And Sennosides tablets is a human otc drug administered via oral route. This formulation utilizes a tablet delivery system. Marketed by Morepen Laboratories Limited, this product is identified by NDC 62993-0002 and is authorized under FDA application M007.

Identification & Billing

NDC Package Code
62993-0002-2
Package Description
60 TABLET in 1 BOTTLE
Product Code
62993-0002
11-Digit Billing Format
62993000202
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
60 EA
RxNorm Crosswalk
  • RxCUI: 998740 - sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet
  • RxCUI: 998740 - docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet
  • RxCUI: 998740 - DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet

Clinical Specifications

Proprietary Name
Docusate Sodium And Sennosides
Non-Proprietary Name
Docusate Sodium And Sennosides
Substance Name
Docusate Sodium; Sennosides
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)

Regulatory & Marketing

Labeler Name
Morepen Laboratories Limited
Product Type
Human Otc Drug
FDA Application #
M007
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
10-01-2025
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (62993-0002). Click a package code to view its specific billing and regulatory data.

62993-0002-1
30 TABLET in 1 BOTTLE
62993-0002-3
100 TABLET in 1 BOTTLE
62993-0002-4
1000 TABLET in 1 BOTTLE
62993-0002-5
3000 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 62993-0002-2 identifies a specific commercial package of 60 tablet in 1 bottle of Docusate Sodium And Sennosides, a human over the counter drug labeled by Morepen Laboratories Limited. This product is billed for "EA" each discreet unit and contains an estimated amount of 60 billable units per package. This tablet is formulated for oral use and contains docusate sodium; sennosides as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Morepen Laboratories Limited on October 01, 2025. The current certification is valid through December 31, 2027.

How is this Morepen Laboratories Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 62993000202. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
62993-0002-2
11-Digit CMS (5-4-2)
62993-0002-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.